GemVax & KAEL Competitors and Similar CompaniesClear all
GemVax & KAEL's competitors and similar companies include Partner Therapeutics, OncoHost and MPC Therapeutics.
 GemVax & KAEL GemVax & KAEL (젬백스앤카엘) is a company that focuses on the manufacturing of coating resins and filters for semiconductors as well as panel display production. |  Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. |  OncoHost OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies. | ||
Founding Date | Founding Date 1998 | Founding Date 2017 | Founding Date 2017 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations KR HQ | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations Binyamina-Giv'at Ada, IL HQ | Locations Geneva, CH HQ |
Employees | Employees 158 | Employees 189 | Employees 562% decrease | Employees 7 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 60m (over 8 years ago) | Latest funding round $ 35m (about 4 years ago) | Latest funding round $ 1.6m (over 3 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 60m | Total funding raised $ 43m | Total funding raised $ 1.6m |
For sources of this data, please see the company profile
View Company Profiles
Partner Therapeutics
HQ
Lexington, US
Employees
189
Partner Therapeutics is developing and commercializing cancer medicines and combination therapies.
View companyOncoHost
HQ
Binyamina-Giv'at Ada, IL
Employees
56↓ 2% decrease
OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.
View company
MPC Therapeutics
HQ
Geneva, CH
Employees
7
MPC Therapeutics is a company that develops drugs for mitochondria.
View company